ArticleNature communications2026

ZNF689 loss impairs homologous recombination sensitizing triple-negative breast cancer to combined PARP and PD-L1 inhibition.

Li-Ping Ge et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.